SCI Abstract

search
Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis
IgA vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common cause of systemic vasculitis in chil...
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease
The antifibrotic therapies nintedanib and pirfenidone were first approved by the United States for the treatment of idiopa...
Psychological profiles in adults with knee OA-related pain: a replication study
Psychological profiles in adults with knee OA-related pain: a replication study
Introduction:Psychological factors have been associated with knee osteoarthritis pain severity and treatment outcomes, yet...
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?
Bronchoalveolar lavage and lung biopsy (LBx) are helpful in patients with connective tissue diseases (CTD) and interstitia...
Radiosynovectomy in routine care: an old tool with modern applications
Radiosynovectomy in routine care: an old tool with modern applications
Objectives:Radiosynovectomy can be an effective treatment for difficult-to-treat monoarthritis resistant to systemic and l...
Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review
Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review
Introduction:The past decade has seen increasingly rapid advances in understanding the pathogenic nature of adult-onset St...
Response to Alvarez et al.
Response to Alvarez et al.
1. Alvarez, G, Zegarra-Parodi, R, Esteves, JE. Person-centered versus body-centered approaches in osteopathic care for chr...
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis
The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis
Despite recent promising developments in the treatment of rheumatoid arthritis (RA), a substantial proportion of patients ...
Soluble biological markers in osteoarthritis
Soluble biological markers in osteoarthritis
In recent years, markers research has focused on the structural components of cartilage matrix. Specifically, a second gen...
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
Natural history and screening of interstitial lung disease in systemic autoimmune rheumatic disorders
Interstitial lung disease (ILD) is a relatively frequent manifestation of systemic autoimmune rheumatic disorders (SARDs),...
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease characterized by inflammation and new bone for...
Corticosteroid injection treatment for dactylitis in psoriatic arthritis
Corticosteroid injection treatment for dactylitis in psoriatic arthritis
Dactylitis – a hallmark clinical feature of psoriatic arthritis (PsA) – that occurs in 30–50% of PsA patients, is a marker...
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
Background:Axial spondyloarthritis (axSpA) patients are known to have a higher prevalence of several comorbidities, includ...
Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
Background:Cardiovascular (CVS) diseases are the leading cause of death worldwide and patients with rheumatic diseases hav...